Tradestie Institutional Equity Comparison Engine
ANRO vs OKUR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANRO Overall Edge
ANRO Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OKUR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ANRO sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ANRO N/M vs OKUR N/M Fwd P/E
Growth & Margin Winner
ANRO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
ANRO
1Y +63.3% vs -2.2% ยท 52W Pos 52% vs 20%
Options & Structure Winner
ANRO
BREAKDOWN (8th %ile IV) vs SURGE (100th %ile IV)
ANRO
NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$25.37
-4.3% 1D
Market Cap
$1.1B
1M Return
+14.28%
1Y Return
+63.26%
Forward P/E
N/M
Unified AI Score
45.8 / 100
HOLD
Tech 44.0
Fund 52.0
Flow 65.0
Mom 50.0
OKUR
NASDAQ
OnKure Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$2.70
-2.17% 1D
Market Cap
$113.7M
1M Return
+4.65%
1Y Return
-2.17%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 20.0
Fund 46.0
Flow 64.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ANRO +63.26%
OKUR -2.17%
Spread: +65.43 pp (ANRO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ANRO TTM Op. Margin: 0.0%
OKUR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANRO vs OKUR. Trailing 12-month operating profitability (ANRO 0.0% vs OKUR 0.0%) and valuation multiples (ANRO N/M vs OKUR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANRO | OKUR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $113.7M | Larger Scale | ANRO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -46.7% | -55.2% | Higher ROE | ANRO |
| 52-Week Range Position Momentum | 52% ($13โ$37) | 20% ($2โ$5) | Stronger Trend | ANRO |
| Beta / 30D Volatility Risk Regime | 1.86ฮฒ ยท 91% Vol | 0.96ฮฒ ยท 100% Vol | Lower Realized Risk | ANRO |
| Unified Institutional Score Composite Signal | 45.8 / 100 (HOLD) | 36.0 / 100 (SELL) | Higher Composite | ANRO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ANRO vs OKUR Buy Guide
ANRO
BREAKDOWN
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
OKUR
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ANRO nor OKUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.